Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study — Stella
Ivosidenib in Locally Advanced or Metastatic Cholangiocarcinoma With IDH1 R132 Mutation After at Least One Prior Systemic Treatment - an Observational Study
Trial locations(7 sites)
Germany
Hämatologisch-Onkologische Schwerpunktpraxis in Bad Liebenwerda, Bad Liebenwerda
Caritas Krankenhaus Bad Mergentheim, Bad Mergentheim
Onkologisches Versorgungszentrum Berlin MVZ, Berlin